Area of Research: Combination Therapy
2022 Grant Recipients
-
Haineng Xu, PhD,
University of Pennsylvania
Early Career Investigator GrantStrategies to Exploit Genetic Alterations in Clear-Cell Ovarian Cancer
2020 Grant Recipients
-
Nidhi Sahni, PhD,
MD Anderson Cancer Center
Early Career Investigator GrantSystems Approach for PARP-based Novel Combination Therapy in Ovarian Cancer
-
James Duncan, PhD,
Fox Chase Cancer Center
Early Career Investigator GrantExploring PROTAC-Mediated Degradation of BRD4 in Ovarian Cancer
2019 Grant Recipients
-
Shariska Petersen, MD,
University of Kansas Medical Center Research Institute
Mentored Investigator GrantCyclin E and BRD4 as Markers for a New PARPi Drug Combination
-
Shuai Wu, PhD,
The Wistar Institute
Mentored Investigator GrantSynthetic Lethality for ARID1A Mutation in Ovarian Cancer
2018 Grant Recipients
-
Gordon Mills, MD, PhD,
MD Anderson Cancer Center
Collaborative Research Development GrantRational Combination Therapy in Ovarian Cancer
2017 Grant Recipients
-
Ronald Chandler, PhD,
Michigan State University
Early Career Investigator GrantIntegrated Roles of Epigenetics and Cell Signaling in Ovarian Cancer
2015 Grant Recipients
-
Bob McGray, PhD,
Roswell Park Cancer Institute
Mentored Investigator GrantCombination Oncolytic Virotherapy/ACT for Ovarian Cancer Treatment
-
Sarah Adams, MD,
University of New Mexico
Early Career Investigator GrantA Combination Therapy for Hereditary Ovarian Cancer
-
Kris Wood, PhD,
Duke University
Early Career Investigator GrantDefining New Combination Therapies for High-grade Serous Ovarian Cancer
2014 Grant Recipients
-
Ursula Matulonis, MD,
Dana Farber Cancer Institute
Collaborative Research Development GrantRational Combinations of Novel Biologic Agents for Ovarian Cancer Therapy
2012 Grant Recipients
-
See-Hyoung Park, PhD,
Stanford University
Mentored Investigator GrantTargeting Ovarian Cancer with Combination of Olaparib and Bepridil
2011 Grant Recipients
-
Sarah Adams, MD,
University of Pennsylvania
Early Career Investigator GrantDevelopment of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer
2005 Grant Recipients
-
Andrew Li, MD,
Cedars-Sinai Medical Center
Early Career Investigator GrantTesting Medications for Other Conditions to Treat Ovarian Cancer
2003 Grant Recipients
-
Parameshwar Mahareshti, DVM,
University of Alabama - Birmingham
Individual Investigator AwardA New Combination Drug Treatment for Ovarian Cancer
2000 Grant Recipients
-
Wei Hu, MD, PhD,
MD Anderson Cancer Center
Individual Investigator AwardEffects of a Novel Combination Drug Treatment on Cell Lines Derived from Human Ovarian Cancer